BioTech 365

FEBRUARY 1, 2022

AscellaHealth Highlights 2022 Key Trends in Specialty Pharmacy: Rising Costs, Expensive Cell/Gene Therapies, Management of Patients on High-Cost Therapies & Vertical Integration of Specialty Pharmacies into Healthcare Organizations AscellaHealth Highlights 2022 Key Trends in Specialty Pharmacy: Rising Costs, Expensive Cell/Gene … Continue (..)

Pharmacy 40

Pharmacy Gene Therapy Gene 40

Pharmaceutical Technology

JANUARY 20, 2023

Following this request, the company was able to get these vaccines into pharmacies within 60 days. Cell & Gene Therapy coverage on Clinical Trials Arena is supported by Cytiva. 5 Omicron variant. We know that outbreaks will happen. How do we stop them from becoming full blown pandemics?” said Bancel.

Manufacturing 246

Manufacturing Vaccine Vaccination Gene Therapy 246

Pharma Mirror

JULY 23, 2021

SOMERSET, N.J.

Manufacturing 130

Manufacturing Gene Therapy Clinical Development Gene 130

Delveinsight

AUGUST 26, 2021

Shape Therapeutics inks gene therapy deal with Roche worth up to USD 3 Billion. Seattle biotech firm Shape Therapeutics has signed a deal potentially exceeding USD 3 billion with pharma giant Roche to bolster the development of gene therapies for Alzheimer’s and Parkinson’s disease.

Vaccination 98

Vaccination Vaccine Gene Therapy RNA 98

pharmaphorum

DECEMBER 2, 2021

As well as being able to make appointments to speak to a doctor, users of the app can also have their prescription sent to a selected pharmacy, check any symptoms of ill-health and manage chronic conditions. The company offers a smartphone application, which can connect patients directly with a healthcare professional.

Genetics 145

Genetics Doctors Doctor Pharmacy 145

Drug Channels

MAY 9, 2023

Last week, Paula and I had the pleasure of attending Asembia’s 2023 Specialty Pharmacy Summit at the wonderful Wynn Las Vegas. As I do every year, I will violate Vegas code and tell you what happened there.

Pharmacy 98

Pharmacy Marketing Drugs Gene Therapy 98

pharmaphorum

JANUARY 11, 2021

Alliance will be able to increase the expansion of its core retail pharmacy business as a result of the transaction, which involves a business that generated revenues of $19 billion in full year 2020. The companies said that the agreement will expand distribution networks for specialty medicines such as cell and gene therapies.

Gene Therapy 84

Gene Therapy Pharmacy Gene Marketing 84

XTalks

SEPTEMBER 13, 2024

Early this year, Elevance closed its acquisition of Paragon Healthcare, enhancing its specialty pharmacy and infusion services capabilities. Billion Cigna continues to innovate by expanding access to healthcare through its diverse portfolio of insurance, pharmacy benefits management and health services. billion in revenue.

Marketing 98

Marketing Pharmacy Gene Therapy Hormones 98

Drug Channels

JUNE 5, 2023

Join peers this August to discover the evolving specialty pharmacy marketplace, build multi-stakeholder partnerships, and explore frameworks to inform your 2024 distribution and patient service strategies.

Pharmacy 74

Pharmacy Gene Therapy Manufacturing Compliance 74

Drug Channels

OCTOBER 17, 2022

Don’t miss the chance to unite with colleagues and master the complexities of pharmacy and distribution models to accelerate patient access! View the agenda to see the complete picture – the program, speakers, and more, and visit www.informaconnect.com/trade for further details and to register.

Pharmacy 75

Pharmacy Gene Therapy Drugs Production 75

Drug Channels

OCTOBER 19, 2020

Channel Strategy for First Medical Product – A Look at Channel Considerations for Pharmacy vs. Medical Plus – Tailored Track Options Based on Company Size : Emerging/Small Companies – Infrastructure Set-Up, License Procurement and 3PL Contracting Mid-Large Companies – How Do I Think About My Portfolio Differently Based on Product Type?

Life Science 52

Life Science Pharmacy Gene Therapy Gene 52

Drug Channels

NOVEMBER 8, 2020

Stuart Parker, Senior Director, Trade Relations, Mayne Pharma And more!

Life Science 52

Life Science Pharmacy Gene Therapy Drugs 52

pharmaphorum

AUGUST 10, 2020

for a single shot of the gene therapy, making it the most expensive drug in the world by many people’s reckoning, although the manufacturer argues this is justified given the costs of treating the condition in later life. But Spinraza costs $750,000 in the first year of treatment and about half that price annually from then on.

FDA Approval 59

FDA Approval Drugs Gene Therapy Protein 59

pharmaphorum

JUNE 27, 2022

Jennifer Mathieu, director of government relations at the Academy of Managed Care Pharmacy (AMCP), tells us why the organisation backed the pre-approval information exchange (PIE) Act of 2022 and how the legislation will empower companies to share information with healthcare payers and plans during the FDA approval process. . Jennifer L.

FDA Approval 95

FDA Approval Manufacturing Clinical Trials Clinical Trials 95

pharmaphorum

FEBRUARY 18, 2022

There are more therapies to choose from and different kinds of treatments such as cell and gene therapies that require entirely different engagement models. Additionally, there is complexity in delivery settings, with sites of care changing and services increasingly delivered in communities or via pharmacies.

Gene Therapy 52

Gene Therapy Pharmacy Gene Marketing 52

XTalks

AUGUST 3, 2023

Raphael Pareschi: I started my career in the pharmaceutical industry 16 years ago, transitioning from a background in pharmacy and biochemistry. What are some of the future challenges you see in the approval of novel treatments, including cell and gene therapies?

Regulation 97

Regulation Marketing Life Science Drugs 97

Drug Channels

FEBRUARY 6, 2024

Access USA will unite PAP – Patient Assistance & Access Programs, Hub and Specialty Pharmacy Models East and the Rare Disease Summit three influential access conferences under one roof for one week of collaborative discussions and opportunities to expand your network and establish powerful partnerships. What is Access USA?

Pharmacy 40

Pharmacy Gene Therapy Pharma Companies Production 40

XTalks

JUNE 4, 2024

Today, there’s been a shift towards more complex, large molecules or biologics like monoclonal antibodies, antibody-drug conjugates (ADCs) and advanced therapies like RNA-based treatments and cell and gene therapies.

Clinical Development 110

Clinical Development Development Clinical Trials Clinical Trials 110

XTalks

MARCH 22, 2023

And drugmakers are using their R&D expenditure to justify setting astronomically high list prices for new therapies. Just last year, the FDA approved a one-time gene therapy treatment for hemophilia B priced at $3.5 million, making it the most expensive drug in the world.

Life Science 97

Life Science Drugs FDA Approval Vaccine 97

Pfizer

SEPTEMBER 27, 2022

In the current broken rebate system, insurers and pharmacy benefit managers negotiate substantial rebates with pharmaceutical companies to lower the price of medicines. Pfizer and Sangamo Therapeutics Announce Phase 3 Trial of Investigational Gene Therapy for Hemophilia A Has Re-Opened Recruitment. Leadership. 09.22.2022.

Medicine 40

Medicine Vaccination Vaccine Gene Therapy 40

Advarra

JULY 28, 2022

This article explores how these tools work and why biosafety cabinets are preferred in research involving cell and gene therapies. While both pieces of equipment are hoods with directional airflow, they function differently and are intended for different purposes. What is a Biosafety Cabinet? appeared first on Advarra.

Contamination 52

Contamination Biohazard Biohazard Production 52

pharmaphorum

FEBRUARY 1, 2021

In a nod to issues related to some of the recent breakthroughs in cell and gene therapies – which are hard to manufacture – the agency is also hoping to hear more from companies to reassure them about production and supply too. More has emerged on the new guidelines following the consultation. In 2020 the value was over €1 billion.

Marketing 52

Marketing Medicine Pharmacy Gene Therapy 52

Drug Channels

DECEMBER 1, 2020

Pharmacy and healthcare provider markets experienced unprecedented volatility. During 2020, the COVID-19 pandemic disrupted every aspect of the pharmaceutical channel—and our lives. If all goes well, 2021 will begin our return to normalcy, as vaccines roll out across the country. This year has demonstrated the underlying resilience of U.S.

Drugs 40

Drugs Pharmacy Vaccination Vaccine 40

XTalks

NOVEMBER 1, 2024

mL, depending on the pharmacy. Why it sold so well: Zolgensma is a gene therapy classified as personalized or precision medicine, as it is designed to address specific issues arising from an individual’s unique genetic code. mL) is around $620 for a supply of 0.25 Price of Zolgensma: Zolgensma has a price of $2.1

FDA Approval 85

FDA Approval Drugs Botox Sales 85

XTalks

AUGUST 30, 2022

We know that a lot of different pathologies, especially as we’ve entered the era of molecular medicine and gene therapies, cause many of the same symptoms and work through final common pathways. However, a drawback is that the dose and neuronal specificity of gene therapy is still poorly understood even in translational models.

Trials 83

Trials Drug Delivery Drugs Gene 83

pharmaphorum

SEPTEMBER 1, 2020

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. Originating as a pharmacy founded in Darmstadt in 1668, it was in 1827 that Heinrich Emanuel Merck began the transition towards an industrial and scientific concern, by manufacturing and selling alkaloids.

Medicine 145

Medicine Insulin Drugs Pharmacy 145

Pharmaceutical Technology

APRIL 24, 2023

Conde says the use of nanoparticle delivery for gene therapies has become more common over recent years. Nanoparticles can be tailored to target specific cells or tissues, release gene therapies in a regulated manner, reduce toxicity, and increase stability,” he added.

Drug Delivery 147

Drug Delivery Vaccination Vaccine Research 147

Pharmaceutical Technology

MAY 24, 2023

The potential regulation, announced on 23 May, includes steps that states can carry out to manage their drug expenditure, particularly in the context of new high-cost treatments such as cell and gene therapies.

Drugs 130

Drugs Manufacturing Vaccine Vaccination 130